Julien Asselineau Selected Research

Julien Asselineau Research Topics

2	Rectal Neoplasms (Rectal Cancer) 01/2020 - 01/2017
2	Residual Neoplasm 01/2020 - 01/2017
2	Thyroid Neoplasms (Thyroid Cancer) 01/2017 - 01/2010
1	Fatigue 01/2021
1	Pain (Aches) 01/2021
1	Multiple System Atrophy 01/2021
1	Multiple Myeloma 09/2020
1	Stroke (Strokes) 01/2019
1	Infarction (Infarctions) 01/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2017
1	Hypercapnia 11/2017
1	Respiratory Insufficiency (Respiratory Failure) 11/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Pituitary ACTH Hypersecretion 02/2015
1	Aphasia (Dysphasia) 04/2013
1	Melanoma (Melanoma, Malignant) 01/2013
1	Hepatitis 12/2010
1	Fibrosis (Cirrhosis) 12/2010
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2010
1	Hepatitis A (Hepatitis, Infectious) 12/2010
1	Type I Syndactyly 12/2009
1	Intracranial Hypertension 11/2008
1	Coma (Comas) 11/2008

2	Sunitinib (Sutent)FDA Link 01/2017 - 01/2010
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	5-HT1A Serotonin ReceptorIBA 01/2021
1	fluoromethylcholineIBA 09/2020
1	IronIBA 01/2019
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2018
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2018
1	lipoarabinomannan (LAM)IBA 11/2018
1	Lomustine (CCNU)FDA Link 11/2018
1	Everolimus FDA Link 11/2017
1	Axitinib (AG 013736)IBA 11/2017
1	IodineIBA 01/2017
1	monodansylthiacadaverineIBA 01/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2015
1	InterferonsIBA 01/2013
1	peginterferon alfa-2b (Pegintron)FDA Link 01/2013
1	Interferon alpha-2 (Roferon-A)FDA Link 01/2013
1	Biomarkers (Surrogate Marker)IBA 12/2010
1	IsoflavonesIBA 12/2009
1	barbituric acid (barbiturate)IBA 11/2008
1	Aligeron (AS 2)IBA 11/2008

2	Chemoradiotherapy 01/2020 - 01/2017
1	Drug Therapy (Chemotherapy) 11/2018
1	Homologous Transplantation 11/2018
1	Noninvasive Ventilation 11/2017
1	Neoadjuvant Therapy 01/2017
1	Language Therapy (Language Training) 04/2013
1	Therapeutics 01/2013